Breast cancer-specific survival associated with breast density

This article originally appeared here.
Breast Density Linked to Breast Cancer-Specific Survival
Breast Density Linked to Breast Cancer-Specific Survival

HealthDay News -- For women with breast cancer receiving adjuvant tamoxifen treatment, a decrease in mammographic density appears to be associated with improved breast cancer-specific survival, according to a study published online April 22 in the Journal of Clinical Oncology.

Jingmei Li, PhD, from the Genome Institute of Singapore, and colleagues examined the extent to which change in mammographic density during adjuvant tamoxifen therapy can be used to measure treatment response in a cohort of 974 postmenopausal patients with breast cancer, of which 474 received tamoxifen and 500 did not.

The researchers found that 12.4% of patients died from breast cancer during 15 years of follow-up. The risk of breast cancer-related death was significantly reduced for women treated with tamoxifen who experienced a relative density reduction of more than 20% from baseline to the first follow-up mammogram (HR, 0.50), compared to those with stable density. There was no significant association between change in mammographic density and survival in the no-tamoxifen group.

"We observed that women treated with tamoxifen who experienced mammographic density reduction were associated with substantially better long-term breast cancer-specific survival," the authors write. "If validated, mammographic density change has the potential to be an early marker for therapy response and provide clinicians with a tool for monitoring the effect of postsurgical adjuvant therapy beyond the current wait-and-see approach."

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs